Labcorp Holdings LH Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 114.2%+0.9pp | 113.2%+0.9pp | 112.3%+0.5pp | 111.8%+0.1pp | 111.7%+0.1pp | |
| Operating margin | 38.6%+1.9pp | 36.7%+1.6pp | 35.2%— | —— | —— | |
| Net margin | 24.8%+1.1pp | 23.7%+0.5pp | 23.2%— | —— | —— | |
| Returns | ||||||
| Return on equity | 41%+2.1pp | 38.9%+1.1pp | 37.8%— | —— | —— | |
| Return on invested capital | 38.7%+1.5pp | 37.2%+1.4pp | 35.8%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 3.1×0.0× | 3.1×0.0× | 3×0.0× | 3×+0.1× | 3×+0.1× | |
| Liquidity | ||||||
| Current ratio | 6.2×-0.1× | 6.3×0.0× | 6.3×+0.1× | 6.2×+0.6× | 5.6×+1.0× | |
| Leverage | ||||||
| Debt-to-equity | 3×0.0× | 2.9×-0.1× | 3.1×-0.1× | 3.2×+0.2× | 3×+0.3× | |
| Net debt / EBITDA | 11.4×-0.6× | 12×-0.4× | 12.4×— | —— | —— | |
| Valuation | ||||||
| Market capitalization | $88.61B+2.9% | $86.11B+1.9% | $84.49B+6.4% | $79.43B+6.5% | $74.57B+1.5% | |
| Price / earnings | 103.8×-3.3× | 107.1×-2.0× | 109×— | —— | —— | |
| Price / sales | 6.4×+0.1× | 6.3×0.0× | 6.3×+0.3× | 6.1×+0.3× | 5.8×0.0× | |
| Price / book | 10.3×+0.2× | 10.1×0.0× | 10.1×+0.4× | 9.6×+0.5× | 9.2×0.0× | |
| EV / EBITDA | 55.5×-1.4× | 56.9×-1.4× | 58.3×— | —— | —— | |
| Dividend yield | 4.4%-0.2pp | 4.5%-0.1pp | 4.6%-0.3pp | 4.9%-0.3pp | 5.3%-0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Labcorp Holdings's profit margins?
- Labcorp Holdings (LH) runs a 28.8% gross margin and a 10.2% operating margin, with a 6.7% net margin.
- Where do Labcorp Holdings's ratios come from?
- Every ratio is computed from Labcorp Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
